HLTHQ

0.00010.00%
RE

Randall E. Pollard

Chief Accounting Officer, Controller & Principal Financial Officer

Mr. Randall E. Pollard, also known as Randy, had been Chief Accounting Officer of Harrow, Inc. from September 1, 2025 until September 4, 2026. He is Controller at Cue Health Inc. since April 2022 and serves as its Principal Financial Officer since May 13, 2024 as well as its Chief Accounting Officer since February 28, 2023. He was Chief Accounting Officer at Cue Health Inc. since April 2022. Mr. Pollard served as Senior Vice President of Finance and Chief Accounting Officer at Covis Pharmaceuticals, Inc. from November 2020 to April 2022. He served as the Chief Accounting Officer of Akorn, Inc. since August 2015 and served as its Senior Vice President since April 2015. Mr. Pollard served as Corporate Controller of Akorn, Inc. since April 2015. and served as its Interim Chief Financial Officer from August 2015 to October 30, 2015 and served as its Vice President. He served in various roles at Akorn, Inc. from April 2015 to November 2020. He oversaw all accounting and financial reporting functions within Akorn. He joined Akorn in 2015 from Novartis Pharmaceuticals, where he served as the Head of Accounting and reporting for Novartis' generic division, Sandoz. During his tenure at Novartis, he also served as Controller of the Sandoz division. Prior to Novartis/Sandoz, he has served in various financial leadership roles at Wyeth and Mayne Pharma. He began his career in public accounting at Arthur Andersen. Mr. Pollard is a Certified Public Accountant. He holds a B.S. in Accounting from Pennsylvania State University and an MBA from Fairleigh Dickinson University.

Positions